Cognition Therapeutics Inc (NASDAQ: CGTX) on Friday, soared 8.48% from the previous trading day, before settling in for the closing price of $1.65. Within the past 52 weeks, CGTX’s price has moved between $0.22 and $3.83.
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -16.44%. The company achieved an average annual earnings per share of 53.20%. With a float of $70.92 million, this company’s outstanding shares have now reached $88.22 million.
Considering the fact that the conglomerate employs 28 people, you should pay attention to its efficiency factor.
Cognition Therapeutics Inc (CGTX) Breakdown of a Key Holders of the stock
Observing investor behavior towards Biotechnology industry stocks is more important than anything else. The insider ownership of Cognition Therapeutics Inc is 19.61%, while institutional ownership is 9.08%. The most recent insider transaction that took place on Jan 31 ’25, was worth 30,001. In this transaction CEO & President of this company bought 38,851 shares at a rate of $0.77, taking the stock ownership to the 38,851 shares.
Cognition Therapeutics Inc (CGTX) Recent Fiscal highlights
As on 9/30/2024, Multinational firm has announced its last quarter scores, in which it reported -0.25 earnings per share (EPS) for the period falling under the consensus outlook (set at -0.21) by -0.04. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.08 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 53.20% per share during the next fiscal year.
Cognition Therapeutics Inc (NASDAQ: CGTX) Trading Performance Indicators
Cognition Therapeutics Inc (CGTX) is currently performing well based on its current performance indicators. A quick ratio of 1.54 was reported for the most recent quarter.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.66, a number that is poised to hit -0.09 in the next quarter and is forecasted to reach -0.28 in one year’s time.
Technical Analysis of Cognition Therapeutics Inc (CGTX)
Compared to the last year’s volume of 4.47 million, its volume of 1.11 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 35.94%.
During the past 100 days, Cognition Therapeutics Inc’s (CGTX) raw stochastic average was set at 43.02%, which indicates a significant decrease from 55.33% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.1356 in the past 14 days, which was lower than the 0.1796 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.9013, while its 200-day Moving Average is $0.8795. Nevertheless, the first resistance level for the watch stands at $1.8667 in the near term. At $1.9433, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.0567. If the price goes on to break the first support level at $1.6767, it is likely to go to the next support level at $1.5633. Now, if the price goes above the second support level, the third support stands at $1.4867.
Cognition Therapeutics Inc (NASDAQ: CGTX) Key Stats
Market capitalization of the company is 157.92 million based on 73,524K outstanding shares. Right now, sales total 0 K and income totals -33,970 K. The company made 0 K in profit during its latest quarter, and -6,730 K in sales during its previous quarter.
